ICNT is a multi-disciplinary, internationally-competitive and well-funded Centre whose research focuses on developing novel, long-acting biotherapeutics for chronic pain.  Recent advances include generation of potent and selective SNARE-proteases that inhibit neuro-exocytosis and give prolonged relief of neuropathic pain in rodents. 

These unique and promising recombinant anti-nociceptives are being produced in a new ‘state-of-the-art’ facility for evaluation in man.